In our studies, the majority of generated hbl cell lines were derived from patients who had already undergone treatment with cisplatin, suggesting that the cells exiting tumor tissue during cell line generation are possibly resistant to cisplatin as part of a selection process. Here, LGALS1 is linked to neoplasm.